Premature pubarche in Mediterranean girls: High prevalence of heterozygous CYP21 mutation carriers

Gynecological Endocrinology

Volumn 26, Issue 5, 2010, Pages 319-324

  Paris, Françoise ^a,b   Tardy, Véronique ^c   Chalançon, Anne ^a,b   Picot, Marie Christine ^b   Morel, Yves ^c   Sultan, Charles ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Adrenal; CYP21 heterozygote; Premature pubarche

Indexed keywords

STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADRENAL HYPERPLASIA; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPERANDROGENISM; PRECOCIOUS PUBERTY; PREVALENCE; PRIORITY JOURNAL; SOUTHERN EUROPE;

EID: 77951127622     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903511505     Document Type: Article

References (40)

1. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche - normal variant or forerunner of adult disease? Endocrinol Rev 2000;21:671-696.
2. Silverman SH, Migeon C, Rosemberg E, Wilkins L. Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence. Pediatrics 1952;10:426-432.
3. Ibanez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, Carrascosa A, Bernasconi S, Vicens-Calvet E. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992;74:254-257.
4. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR, Rainey WE. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000;53:739-747.
5. Zhang LH, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 1995;92:10619-10623.
6. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, Rainey WE. Adrenarche results from development of a 3betahydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab 1998;83:3695-3701.
7. Vottero A, Capelletti M, Giuliodori S, Viani I, Ziveri M, Neri TM, Bernasconi S, Ghizzoni L. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? J Clin Endocrinol Metab 2006;91:968-972.
8. Voutilainen R, Perheentupa J, Apter D. Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatr Scand 1983;72:707-711.
9. Auchus RJ, Rainey WE. Adrenarche - physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 2004;60:288-296.
10. Likitmaskul S, Cowell CT, Donaghue K, Kreutzmann DJ, Howard NJ, Blades B, Silink M. 'Exaggerated adrenarche' in children presenting with premature adrenarche. Clin Endocrinol (Oxf) 1995;42:265-272.
11. Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V. Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 1994;79:582-589.
12. Hawkins LA, Chasalow FI, Blethen SL. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/ oligomenorrhea. J Clin Endocrinol Metab 1992;74:248-253.
13. Knorr D, Bidlingmaier F, Holler W, Kuhnle U, Meiler B, Nachmann A. Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children? Acta Endocrinol Suppl (Copenh) 1986;279:284-289.
14. Dacou-Voutetakis C, Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. J Clin Endocrinol Metab 1999;84: 1570-1574.
15. Potau N, Rique S, Eduardo I, Marcos V, Ibanez L. Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche. Eur J Endocrinol 2002;147:485-488.
16. Witchel SF, Smith R, Tomboc M, Aston CE. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 2001;75:724-730.
17. Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol (Oxf) 2006;64:645-651.
18. Bojunga J, Welsch C, Antes I, Albrecht M, Lengauer T, Zeuzem S. Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21- hydroxylase deficiency. Hum Genet 2005;117:558-564.
19. Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway- Myers BA, Dewailly D, Azziz R. Carriers of 21- hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 1997;82:479-485.
20. Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update 2004;10:469-485.
21. New MI. Extensive clinical experience: nonclassical 21- hydroxylase deficiency. J Clin Endocrinol Metab 2006;91: 4205-4214.
22. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford: Stanford University Press; 1966.
23. Forest MG, Pugeat M, Monneret MP, Rigaud C, David M, Morel Y. Normative data for the response of plasma 21- deoxycortisol to ACTH stimulation: efficient screening test for heterozygocy of 21-hydroxylase (21-OH) deficiency in the general population. Horm Res 1994;41:110.
24. Menassa R, Tardy V, Despert F, Bouvattier-Morel C, Brossier JP, Cartigny M, Morel Y. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008;93:1901-1908.
25. Tardy V, Forest MG, De Rougemont A, Morel Y. Detection of heterozygotes for 21-hydroxylase deficiency: validation of 21-deoxycortisol after ACTH test by sequencing of the entire CYP21 gene. Horm Res 2005;64:41.
26. Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D, Morel Y, Kuttenn F. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2001;86:207-213.
27. Tardy V, Carel JC, Forest MG, NicolinoM, Tauber M, Raux- Demay MC, David A, Morel Y. Nonclassical forms of 21- hydroxylase deficiency revisited by molecular biology. Horm Res 1996;46:9.
28. Del Balzo P, Borrelli P, Cambiaso P, Danielli E, Cappa M. Adrenal steroidogenic defects in children with precocious pubarche. Horm Res 1992;37:180-184.
29. Ibanez L, Bonnin MR, Zampolli M, Prat N, Alia PJ, Navarro MA. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche. Horm Res 1995;44:51-56.
30. Siegel SF, Finegold DN, Urban MD, McVie R, Lee PA. Premature pubarche: etiological heterogeneity. J Clin Endocrinol Metab 1992;74:239-247.
31. Temeck JW, Pang SY, Nelson C, New MI. Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab 1987;64:609-617.
32. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI. A segregation and linkage study of classical and nonclassical 21- hydroxylase deficiency. Am J Hum Genet 1988;42:830-838.
33. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:650-667.
34. Zerah M, Ueshiba H, Wood E, Speiser PW, Crawford C, McDonald T, Pareira J, Gruen D, New MI. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. J Clin Endocrinol Metab 1990;70:1662-1667.
35. Blanche H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E, Dausset J, Bellanne-Chantelot C. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet 1997;101:56-60.
36. Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21- hydroxylase deficiency. Biochem Mol Med 1997;62:151-158.
37. Escobar-Morreale HF, San Millan JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril 1999;72:629-638.
38. Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MH, Honour JW. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf) 1998;48:209-215.
39. Lajic S, Clauin S, Robins T, Vexiau P, Blanche H, Bellanne-Chantelot C, Wedell A. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 2002;87:2824-2829.
40. Bachega TA, Brenlha EM, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonca BB. Variable ACTHstimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations. J Clin Endocrinol Metab 2002;87:786-790.